October 17th 2024.
Dementia Australia, the leading organization that provides support to individuals living with dementia, expressed their disappointment after the Therapeutic Goods Administration (TGA) rejected a potential Alzheimer's drug in Australia. The drug in question, called Lecanemab, is known to remove amyloid plaques from the brain, which can slow the cognitive decline associated with Alzheimer's disease, according to Dementia Australia.
While the drug has been approved for use in various countries such as the UK, USA, China, Japan, South Korea, Hong Kong, United Arab Emirates, and Israel, the TGA rejected its use in Australia. Dementia Australia's chief executive, Professor Tanya Buchanan, stated that this decision limits the options for Australians seeking treatment for their condition.
"We have the utmost respect for the TGA as Australia's medicines regulator, but if this decision is upheld, it will be a setback for Australians who could have potentially benefited from Lecanemab," Buchanan expressed. "It is disappointing that Australians living with early-stage Alzheimer's may not have access to the same treatment options as those in other countries."
Buchanan also clarified that Lecanemab is not a cure for Alzheimer's and is not suitable for all individuals diagnosed with the disease. Like most medicines, it comes with significant risks. However, it is considered a significant milestone in the fight against Alzheimer's and brings hope for those living with the condition.
The rejection of Lecanemab by the TGA follows a similar decision by the European Medicines Agency last year, which was also met with criticism from Alzheimer's organizations in Europe. Despite the setbacks, many still view Lecanemab as a groundbreaking development in the quest to reduce the impact of Alzheimer's disease.
On a different note, in the news, former One Direction star Liam Payne's passing has left many in shock. Meanwhile, a 33-year-old property mogul who owns a staggering 110 homes worth $90 million recently shared that he treats the housing market like a game of Monopoly.
[This article has been trending online recently and has been generated with AI. Your feed is customized.]
[Generative AI is experimental.]
